Mechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 Diabetes
Clinical trial NCT02372955 · UNKNOWN
Trial details
- NCT number
- NCT02372955
- Sponsor
- Gulf Regional Research & Educational Services, LLC
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2016-02-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.